Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2011, Vol. 9 ›› Issue (1): 38-48.doi: 10.3736/jcim20110108

• Original Experimental Research • Previous Articles     Next Articles

Chinese herbal medicine Naoxintong capsule combined with dual antiplatelet therapy in a rat model of coronary microembolization induced by homologous microthrombi

Ming-wei Huang, Huan Wang, Wen-juan Zhong, Xiao-ying Wu, Hui Chen()   

  1. Department of Cardiology, Fujian Provincial Hospital, Fujian Medical University, Fujian Provincial Cardiovascular Disease Institute, Fuzhou 350001,Fujian Province, China
  • Received:2010-08-15 Accepted:2010-09-13 Online:2011-01-20 Published:2011-01-15
  • Contact: Chen Hui

Objective: In the present study, the efficacy of Naoxintong capsule (NXT), a compound Chinese herbal medicine, combined with dual antiplatelet therapy (DA) in a rat model of coronary microembolization (CME) was evaluated.
Methods: CME in rats was developed by injecting a suspension of microthrombotic particles into the left ventricle when the ascending aorta was obstructed. Microthrombotic particles were generated from the clots of rats sized by filtration through a screen (aperture diameter, 38 μm). A total of 95 rats were randomly divided into six groups, including control group, sham-operation (sham) group, CME model (CME) group, and NXT, DA, and NDA (NXT plus DA) groups. Rats in treatment groups were administered intragastrically with NXT, DA, and NDA, respectively, from 3 d before to 7 d after operation. All rats were sacrificed on day 7 post-operationally, and samples of blood and heart were collected. The complete data of 69 rats were obtained. The incidence of CME (CME%) was evaluated by hematoxylin-eosin staining. Bleeding time (BT) and clotting time (CT) were measured by means of tail cutting and glass slide methods, respectively. Adenosine diphosphate-induced maximum platelet aggregation rate (PAR) was assessed with turbidimetry. Platelet counts were examined by an automated hematology analyzer. The levels of serum P-selectin, interleukin (IL)-6, IL-10, endothelin (ET-1) and endothelial nitric oxide synthase (eNOS) were all detected by enzyme-linked immunosorbent assay.
Results: Compared with control and sham groups, CME group had an increase in CME%, PAR, P-selectin, IL-6 and ET-1 (P<0.01, P<0.01), and a decrease in BT, CT, IL-10 and eNOS (P<0.01, P<0.01); compared with CME group, the groups receiving medications had an increase in BT, CT, IL-10 and eNOS (P<0.05 or P<0.01), and a decrease in CME%, PAR, P-selectin, IL-6 and ET-1 (P<0.05 or P<0.01), with DA group increasing most in BT and CT and decreasing most in PAR and P-selectin, and with NDA group increasing most in IL-10 and eNOS and decreasing most in CME%, IL-6 and ET-1. In terms of platelet counts, there was no statistically significant difference among groups (P>0.05).
Conclusion: NXT combined with DA can decrease CME%. The probable mechanism is that this therapy can appropriately inhibit platelet aggregation, balance the pro- and anti-inflammatory cytokines as well as serum ET-1 and eNOS. This therapy can also reduce risk of intraoperative bleeding during DA therapy.

Key words: Naoxintong, Chinese patent drugs, coronary thrombosis, platelet aggregation inhibitors, chemokines, animal experimentation, rats


Figure 1

Microemboli in coronary arterioles (50 to 100 μm) of coronary microembolization model ratsHematoxylin-eosin staining (Light microscopy, ×400); bar in the photograph represents 20 μm."

Figure 2

Morphological changes of CME% in different groups The morphological changes were detected by HE staining (Light microscopy, ×100). A: Control group; B: Sham-operation group; C: Coronary microembolization model group; D: Naoxintong capsule group; E: Dual antiplatelet therapy group; F: Naoxintong capsule plus dual antiplatelet therapy group. Bars in the photographs represent 20 μm."





[1] Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R; RAVEL Study Group . A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization[J]. N Engl J Med, 2002,346(23):1773-1780
doi: 10.1056/NEJMoa012843
[2] Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR , O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators.Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery[J]. N Engl J Med, 2003,349(14):1315-1323
doi: 10.1056/NEJMoa035071
[3] Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD . Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious[J]. Circulation, 2004,109(6):701-705
doi: 10.1161/01.CIR.0000116202.41966.D4
[4] Camenzind E, Steg PG, Wijns W . Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern[J]. Circulation, 2007,115(11):1440-1455
doi: 10.1161/CIRCULATIONAHA.106.666800
[5] Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G , Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW.Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study[J]. Lancet, 2007,369(9562):667-678
doi: 10.1016/S0140-6736(07)60314-6
[6] Wenaweser P, Daemen J , Zwahlen M, van Domburg R, Jüni P, Vaina S, Hellige G, Tsuchida K, Morger C, Boersma E, Kukreja N, Meier B, Serruys PW, Windecker S.Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: 4-year results from a large 2-institutional cohort study[J]. J Am Coll Cardiol, 2008,52(14):1134-1140
doi: 10.1016/j.jacc.2008.07.006
[7] Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK . Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation[J]. N Engl J Med, 2001,345(7):494-502
doi: 10.1056/NEJMoa010746
[8] Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA . Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study[J]. Lancet, 2001,358(9281):527-533
doi: 10.1016/S0140-6736(01)05701-4
[9] Tavassoli N, Voisin S, Carrie D, Lapeyre-Mestre M, Galinier M, Montastruc JL, Pathak A . High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients[J]. Am J Cardiovasc Drugs, 2010,10(1):29-35
doi: 10.2165/11318260-000000000-00000
[10] Sibbing D, Schulz S, Braun S, Morath T, Stegherr J, Mehilli J , Schömig A, von Beckerath N, Kastrati A.Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement[J]. J Thromb Haemost, 2010,8(2):250-256
doi: 10.1111/jth.2010.8.issue-2
[11] Ben-Dor I, Torguson R, Scheinowitz M, Li Y, Delhaye C, Wakabayashi K, Maluenda G, Syed AI, Collins SD, Gonzalez MA, Gaglia MA Jr, Xue Z, Kaneshige K, Satler LF, Suddath WO, Kent KM, Pichard AD, Waksman R . Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents[J]. Am Heart J, 2010,159(5):871-875
doi: 10.1016/j.ahj.2010.01.016
[12] Chen C, Venketasubramanian N, Gan RN, Lambert C, Picard D, Chan BP, Chan E, Bousser MG, Xuemin S.Danqi Piantang Jiaonang ( DJ), a traditional Chinese medicine, in poststroke recovery[J]. Stroke, 2009,40(3):859-863
doi: 10.1161/STROKEAHA.108.531616
[13] Chen DK, Zhang HQ, Zhang JH . Intervening effect of Naoxintong on anti-platelet treatment with aspirin[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2008,28(9):843-846
陈达开, 张怀勤, 张建华 . 脑心通对阿司匹林抗血小板治疗的干预作用[J]. 中国中西医结合杂志, 2008,28(9):843-846
[14] World Medical Association, American Physiological Society . Guiding principles for research involving animals and human beings[J]. Am J Physiol Regul Integr Comp Physiol, 2002,283(2):R281-R283
doi: 10.1152/ajpregu.00279.2002
[15] Kudo M, Aoyama A, Ichimori S, Fukunaga N . An animal model of cerebral infarction. Homologous blood clot emboli in rats[J]. Stroke, 1982,13(4):505-508
doi: 10.1161/01.STR.13.4.505
[16] Li S, Zhong S, Zeng K, Luo Y, Zhang F, Sun X, Chen L . Blockade of NF-κB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats[J]. Basic Res Cardiol, 2010,105(1):139-150
doi: 10.1007/s00395-009-0067-6
[17] Erbel R, Heusch G . Coronary microembolization[J]. J Am Coll Cardiol, 2000,36(1):22-24
doi: 10.1016/S0735-1097(00)00708-7
[18] Topol EJ, Yadav JS . Recognition of the importance of embolization in atherosclerotic vascular disease[J]. Circulation, 2000,101(5):570-580
doi: 10.1161/01.CIR.101.5.570
[19] Herrmann J . Peri-procedural myocardial injury: 2005 update[J]. Eur Heart J, 2005,26(23):2493-2519
doi: 10.1093/eurheartj/ehi455
[20] Galiuto L, Garramone B, Burzotta F, Lombardo A, Barchetta S, Rebuzzi AG, Crea F; REMEDIA Investigators . Thrombus aspiration reduces microvascular obstruction after primary coronary intervention: a myocardial contrast echocardiography substudy of the REMEDIA Trial[J]. J Am Coll Cardiol, 2006,48(7):1355-1360
doi: 10.1016/j.jacc.2006.05.059
[21] Srinivasan M, Rihal C, Holmes DR, Prasad A . Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes[J]. Circulation, 2009,119(9):1311-1319
doi: 10.1161/CIRCULATIONAHA.108.831453
[22] Heusch G, Schulz R, Haude M, Erbel R . Coronary microembolization[J]. J Mol Cell Cardiol, 2004,37(1):23-31
doi: 10.1016/j.yjmcc.2004.04.011
[23] Lee KW, Norell MS . Management of ‘no-reflow’ complicating reperfusion therapy[J]. Acute Card Care, 2008,10(1):5-14
[24] Pasceri V, Patti G, Di Sciascio G . Prevention of myocardial damage during coronary intervention[J]. Cardiovasc Hematol Disord Drug Targets, 2006,6(2):77-83
[25] Davies MJ, Thomas AC, Knapman PA, Hangartner JR . Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death[J]. Circulation, 1986,73(3):418-427
doi: 10.1161/01.CIR.73.3.418
[26] Valero SJ, Moreno R, Reyes RM, Recalde AS, Galeote G, Calvo L, Villate A, Sendón JL . Pharmacological approach of no-reflow phenomenon related with percutaneous coronary interventions[J]. Cardiovasc Hematol Agents Med Chem, 2008,6(2):125-129
doi: 10.2174/187152508783955079
[27] Ivandic BT, Sausemuth M, Ibrahim H, Giannitsis E, Gawaz M, Katus HA . Dual antiplatelet drug resistance is a risk factor for cardiovascular events after percutaneous coronary intervention[J]. Clin Chem, 2009,55(6):1171-1176
doi: 10.1373/clinchem.2008.115089
[28] Xing YN, Yang GJ, Liu SN, Wu B, Xu N . The research outline of blood stasis syndrome in coronary heart disease[J]. Zhongguo Yi Yao Dao Bao, 2009,6(2):5-6
邢亚楠, 杨冠军, 刘苏宁, 吴蓓, 许宁 . 冠心病血瘀证研究概述[J]. 中国医药导报, 2009,6(2):5-6
[29] Praticò D, Tillmann C, Zhang ZB, Li H , FitzGerald GA.Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice[J]. Proc Natl Acad Sci U S A, 2001,98(6):3358-3363
doi: 10.1073/pnas.061607398
[30] Ruggeri ZM . Platelets in atherothrombosis[J]. Nat Med, 2002,8(11):1227-1234
doi: 10.1038/nm1102-1227
[31] Antiplatelet Trialists’ Collaboration . Collaborative overview of randomised trials of antiplatelet therapy — Ⅰ: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients[J]. BMJ, 1994,308(6921):81-106
doi: 10.1136/bmj.308.6921.81
[32] Lardizabal JA, Joshi BK, Ambrose JA . The balance between anti-ischemic efficacy and bleeding risk of antithrombotic therapy in percutaneous coronary intervention: a yin-yang paradigm[J]. J Invasive Cardiol, 2010,22(6):284-292
[33] Libby P . Vascular biology of atherosclerosis: overview and state of the art[J]. Am J Cardiol, 2003,91(3A):3A-6A
[34] Woods A, Brull DJ, Humphries SE, Montgomery HE . Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6[J]. Eur Heart J, 2000,21(19):1574-1583
doi: 10.1053/euhj.1999.2207
[35] Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V . Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link[J]. Atherosclerosis, 2000,148(2):209-214
doi: 10.1016/S0021-9150(99)00463-3
[36] Chalikias GK, Tziakas DN, Kaski JC, Hatzinikolaou EI, Stakos DA, Tentes IK, Kortsaris A, Hatseras DI . Interleukin-18︰interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome[J]. Atherosclerosis, 2005,182(1):135-143
doi: 10.1016/j.atherosclerosis.2005.02.002
[37] Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A . Protective role of interleukin-10 in atherosclerosis[J]. Circ Res, 1999,85(8):e17-e24
[38] Terkeltaub RA . IL-10: an “immunologic scalpel” for atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 1999,19(12):2823-2825
doi: 10.1161/01.ATV.19.12.2823
[39] Terkeltaub RA.Libby P , Simon DI[J]. Inflammation and thrombosis: the clot thickens, 2001,103(13):1718-1720
[40] Martin DM, Boys CW, Ruf W . Tissue factor: molecular recognition and cofactor function[J]. FASEB J, 1995,9(10):852-859
doi: 10.1096/fasebj.9.10.7615155
[41] Nachman RL . Thrombosis and atherogenesis: molecular connections[J]. Blood, 1992,79(8):1897-1906
[42] Rodgers GM . Hemostatic properties of normal and perturbed vascular cells[J]. FASEB J, 1988,2(2):116-123
doi: 10.1096/fasebj.2.2.3277885
[43] Zouridakis EG, Schwartzman R, Garcia-Moll X, Cox ID, Fredericks S, Holt DW, Kaski JC . Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression[J]. Eur Heart J, 2001,22(17):1578-1584
doi: 10.1053/euhj.2000.2588
[44] Rodeberg DA, Chaet MS, Bass RC, Arkovitz MS, Garcia VF . Nitric oxide: an overview[J]. Am J Surg, 1995,170(3):292-303
doi: 10.1016/S0002-9610(05)80017-0
[45] Ulker S , McKeown PP, Bayraktutan U.Aprotinin impairs coronary endothelial function and down-regulates endothelial NOS in rat coronary microvascular endothelial cells[J]. Cardiovasc Res, 2002,55(4):830-837
doi: 10.1016/S0008-6363(02)00489-3
[1] Morufu Eyitayo Balogun, Elizabeth Enohnyaket Besong, Jacinta Nkechi Obimma, Ogochukwu Sophia Mbamalu, Fankou Serges Athanase Djobissie. Protective roles of Vigna subterranea (Bambara nut) in rats with aspirin-induced gastric mucosal injury. Journal of Integrative Medicine, 2018, 16(5): 342-349.
[2] Lucky Legbosi Nwidu, Raphael Ellis Teme. Hot aqueous leaf extract of Lasianthera africana (Icacinaceae) attenuates rifampicin-isoniazid-induced hepatotoxicity. Journal of Integrative Medicine, 2018, 16(4): 263-272.
[3] Kylie Connolly, Douglas Jackson, Candice Pullen, Andrew Fenning. Alpha-adrenoceptor antagonism by Crassostrea gigas oyster extract inhibits noradrenaline-induced vascular contraction in Wistar rats. Journal of Integrative Medicine, 2015, 13(3): 194-200.
[4] Hussein O. B. Oloyede, Matthew C. Adaja, Taofeek O. Ajiboye, Musa O. Salawu. Anti-ulcerogenic activity of aqueous extract of Carica papaya seed on indomethacin-induced peptic ulcer in male albino rats. Journal of Integrative Medicine, 2015, 13(2): 105-114.
[5] Udhaya Lavinya Baskaran, Sherry Joseph Martin, Rasool Mahaboobkhan, Sabina Evan Prince. Protective role of Triphala, an Indian traditional herbal formulation, against the nephrotoxic effects of bromobenzene in Wistar albino rats. Journal of Integrative Medicine, 2015, 13(2): 115-121.
[6] Anirudha A. Lande, Shirishkumar D. Ambavade, Uma S. Swami, Prafulla P. Adkara Prashant D. Ambavade, Arun B. Waghamare. Saponins isolated from roots of Chlorophytum borivilianum reduce acute and chronic inflammation and histone deacetylase. Journal of Integrative Medicine, 2015, 13(1): 25-33.
[7] Elizabeth Abidemi Balogun, Sylvia Orume Malomo, Joseph Oluwatope Adebayo, Ahmed Adebayo Ishola, Ayodele Olufemi Soladoye, Lawrence Aderemi Olatunji, Olatunji Matthew Kolawole, Stephen Olubunmi Oguntoye, Abiola Samuel Babatunde, Oluwole Busayo Akinola . In vivo antimalarial activity and toxicological effects of methanolic extract of Cocos nucifera (Dwarf red variety) husk fibre. Journal of Integrative Medicine, 2014, 12(6): 504-511.
[8] Xin-fang Zhang, Ji Zhu, Wen-ye Geng, Shu-jun Zhao, Chuan-wei Jiang, Sheng-rong Cai, Miao Cheng, Chuan-yun Zhou, Zi-bing Liu. Electroacupuncture at Feishu (BL13) and Zusanli (ST36) down-regulates the expression of orexins and their receptors in rats with chronic obstructive pulmonary disease. Journal of Integrative Medicine, 2014, 12(5): 417-424.
[9] Urmila Aswar, Mayuri Gurav, Ganesh More, Khaled Rashed, Manoj Aswar. Effect of aqueous extract of Solanum xanthocarpum Schrad. & Wendl. on postmenopausal syndrome in ovariectomized rats. Journal of Integrative Medicine, 2014, 12(5): 439-446.
[10] Benjamin Perry, Junzeng Zhang, Tarek Saleh, Yanwen Wang. Liuwei Dihuang, a traditional Chinese herbal formula, suppresses chronic inflammation and oxidative stress in obese rats. Journal of Integrative Medicine, 2014, 12(5): 447-454.
[11] Upendarrao Golla, Praveen Kumar Gajam, Solomon Sunder Bhimathati. Evaluation of diuretic and laxative activity of hydro-alcoholic extract of Desmostachya bipinnata (L.) Stapf in rats. Journal of Integrative Medicine, 2014, 12(4): 372-378.
[12] Qian Zhang, Xin-hua Xiao, Ming Li, Wen-hui Li, Miao Yu, Hua-bing Zhang, Fan Ping, Zhi-xin Wang, Jia Zheng ​. Chromium-containing traditional Chinese medicine, Tianmai Xiaoke Tablet improves blood glucose through activating insulin-signaling pathway and inhibiting PTP1B and PCK2 in diabetic rats. Journal of Integrative Medicine, 2014, 12(3): 162-170.
[13] Amir Rashidian​, Saeed Mehrzadi, Ali Reza Ghannadi, Parvin Mahzooni, Samira Sadr, Mohsen Minaiyan​. Protective effect of ginger volatile oil against acetic acid-induced colitis in rats: A light microscopic evaluation. Journal of Integrative Medicine, 2014, 12(2): 115-120.
[14] Dilpesh Jain​, Manish Kumar Bansal, Rahul Dalvi​, Aman Upganlawar​, Rahul Somani​. Protective effect of diosmin against diabetic neuropathy in experimental rats. Journal of Integrative Medicine, 2014, 12(1): 35-41.
[15] Manjusha Choudhary​, Vipin Kumar​, Surender Singh​. Gastric antisecretory and cytoprotective effects of hydroalcoholic extracts of Plumeria alba Linn. leaves in rats. Journal of Integrative Medicine, 2014, 12(1): 42-51.
Full text



[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[3] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[4] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[5] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[6] Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047
[7] Bing Hu , Hong-mei An , Ke-ping Shen , Qin Du. Senescence-inducing effects of Chinese herbal medicine Tenglong Buzhong Decoction on human colon carcinoma LS-174-T cells and the mechanism. Journal of Chinese Integrative Medicine, 2010, 8(11): 1048-1052
[8] Ya-hui Liang , Ping Li, Jing-xia Zhao, Xin Liu, Qi-fu Huang. Acetyl-11-keto-beta-boswellic acid and arsenic trioxide regulate the productions and activities of matrix metalloproteinases in human skin fibroblasts and human leukemia cell line THP-1. Journal of Chinese Integrative Medicine, 2010, 8(11): 1060-1069
[9] Chan Chen, Yong-mei Meng , Peng Zhang, Juan Wang, Hui-hui Zhao, Shu-zhen Guo , Wei Wang. Diagnosis and treatment rule of traditional Chinese medicine for syndrome factors of chronic congestive heart failure: a study based on Shannon entropy method. Journal of Chinese Integrative Medicine, 2010, 8(11): 1080-1084
[10] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100